Prezista label
Cmax decrease 17%, AUC decrease 13%, Cmin increase 1%
Cmax increase 26%, AUC increased 57%, Cmin increase 174%
Increased risk of antibacterial adverse effects
In patients with CrCl 30-60 mL / min, reduce dose of clarithromycin by 50%. In patients with CrCl <30 mL / min, reduce clarithromycin dose by 75%. Monitor for clarithromycin-related toxicities and / or consider alternative macrolide.

